1-Aroylindoline-hydroxamic acids as anticancer agents, inhibitors of HSP90 and HDAC-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

1-Aroylindoline-hydroxamic acids as anticancer agents, inhibitors of HSP90 and HDAC

Published:2018-04 Issue: Volume:150 Page:667-677
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Ojha Ritu,Huang Han-Li,HuangFu Wei-Chun,Wu Yi-Wen,Nepali Kunal,Lai Mei-Jung,Su Chih-Jou,Sung Ting-Yi,Chen Yi-Lin,Pan Shiow-Lin,Liou Jing-Ping

Funder

Ministry of Science and Technology

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference42 articles.

1. Rational approaches, design strategies, structure activity relationship and mechanistic insights for anticancer hybrids;Nepali;Eur. J. Med. Chem.,2014

2. Design and synthesis of dual-action inhibitors targeting histone deacetylases and 3-Hydroxy-3-methylglutaryl coenzyme a reductase for cancer treatment;Chen;J. Med. Chem.,2013

3. Multi-Targeted anticancer agents;Zheng;Curr. Top. Med. Chem.,2017

4. A.B.,Multi-Targeted agents in cancer cell chemosensitization: what we learnt from curcumin thus far, recent pat;Bordoloi;Anti. Drug. Discov.,2016

5. Dual inhibition of histone deacetylases and phosphoinositide 3-kinase enhances therapeutic activity against B cell lymphoma;Mondello;Oncotarget,2017

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting HSP90 for Cancer Therapy: Current Progress and Emerging Prospects;Journal of Medicinal Chemistry;2024-09-10

2. Small molecules targeting HDAC6 for cancer treatment: Current progress and novel strategies;Biomedicine & Pharmacotherapy;2024-09

3. Small molecule inhibitors targeting heat shock protein 90: An updated review;European Journal of Medicinal Chemistry;2024-09

4. Advances in targeting histone deacetylase for treatment of solid tumors;Journal of Hematology & Oncology;2024-05-31

5. Dual inhibition of CYP17A1 and HDAC6 by abiraterone-installed hydroxamic acid overcomes temozolomide resistance in glioblastoma through inducing DNA damage and oxidative stress;Cancer Letters;2024-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3